Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
May 28, 2018

He's long BAC and prefers US to Canadian banks. Expect share buybacks by BAC for the next five years. There's a long runway here.

He's long BAC and prefers US to Canadian banks. Expect share buybacks by BAC for the next five years. There's a long runway here.

Wolfgang Klein
Senior investment advisor, Canaccord Genuity Wealth Management
Price
$30.160
Owned
Yes
WATCH
WATCH
May 28, 2018

It's a winning story. It's on his watch list. Don't double down following the recent pullback--doubling down isn't he style of investing.

It's a winning story. It's on his watch list. Don't double down following the recent pullback--doubling down isn't he style of investing.

Wolfgang Klein
Senior investment advisor, Canaccord Genuity Wealth Management
Price
$55.020
Owned
No
HOLD
HOLD
May 28, 2018

Don't add to a losing position or sell it here given the recent drop in oil. He likes this name.

Don't add to a losing position or sell it here given the recent drop in oil. He likes this name.

Wolfgang Klein
Senior investment advisor, Canaccord Genuity Wealth Management
Price
$50.170
Owned
Unknown
DON'T BUY
DON'T BUY
May 28, 2018

Not cheap, based on its historic valuation. Fundamentally, it's a good business, but its chart is unhealthy. Healthcare should be in any portfolio and this is a quality company. But Celgene ranks near the bottom of his medical/health stocks, 45 out of 49.

Not cheap, based on its historic valuation. Fundamentally, it's a good business, but its chart is unhealthy. Healthcare should be in any portfolio and this is a quality company. But Celgene ranks near the bottom of his medical/health stocks, 45 out of 49.

Wolfgang Klein
Senior investment advisor, Canaccord Genuity Wealth Management
Price
$78.630
Owned
No
DON'T BUY
DON'T BUY
May 28, 2018

He already bought and sold it, but wouldn't buy it here. It's well-funded and well-run. THCX was waiting for a contract from the Quebec government, so it's a good story and will be profitable. But it's had a good run for now. He'd rather buy HMMJ--individual companies are so volatile.

Hexo Corp (HEXO-T)
May 28, 2018

He already bought and sold it, but wouldn't buy it here. It's well-funded and well-run. THCX was waiting for a contract from the Quebec government, so it's a good story and will be profitable. But it's had a good run for now. He'd rather buy HMMJ--individual companies are so volatile.

Wolfgang Klein
Senior investment advisor, Canaccord Genuity Wealth Management
Price
$5.890
Owned
No
BUY
BUY
May 28, 2018

He'd rather buy HMMJ--individual companies are too volatile. Looking ahead: the price of bud will go lower. The next stage is profitability, especially when the big banks get involved. That will be a game-changer and exciting, but this will take time.

He'd rather buy HMMJ--individual companies are too volatile. Looking ahead: the price of bud will go lower. The next stage is profitability, especially when the big banks get involved. That will be a game-changer and exciting, but this will take time.

Wolfgang Klein
Senior investment advisor, Canaccord Genuity Wealth Management
Price
$17.890
Owned
Yes
COMMENT
COMMENT
May 28, 2018

It's a winner. It's working, but he can't figure it out. He's rather own Google or Amazon--online companies he knows and understands.

It's a winner. It's working, but he can't figure it out. He's rather own Google or Amazon--online companies he knows and understands.

Wolfgang Klein
Senior investment advisor, Canaccord Genuity Wealth Management
Price
$199.200
Owned
No